Deferred Income Tax Liabilities, Net of IDEXX LABORATORIES INC /DE from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
IDEXX LABORATORIES INC /DE quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $3,724,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,724,000 -$1,934,000 -34% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $2,088,000 -$7,935,000 -79% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $8,110,000 -$636,000 -7.3% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $11,312,000 +$4,077,000 +56% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $5,658,000 -$4,936,000 -47% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $10,023,000 +$4,455,000 +80% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $8,746,000 +$2,920,000 +50% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $7,235,000 -$915,000 -11% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $10,594,000 -$3,892,000 -27% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $5,568,000 -$5,284,000 -49% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $5,826,000 -$1,635,000 -22% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $8,150,000 -$785,000 -8.8% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $14,486,000 -$820,000 -5.4% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $10,852,000 -$4,617,000 -30% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $7,461,000 -$11,105,000 -60% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $8,935,000 -$2,772,000 -24% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $15,306,000 -$12,284,000 -45% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $15,469,000 -$21,130,000 -58% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $18,566,000 -$20,342,000 -52% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $11,707,000 -$21,317,000 -65% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $27,590,000 -$6,144,000 -18% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $36,599,000 +$4,184,000 +13% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $38,908,000 +$5,977,000 +18% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $33,024,000 +$3,757,000 +13% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $33,734,000 -$6,165,000 -15% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $32,415,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $32,931,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $29,267,000 +$3,914,000 +15% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $39,899,000 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q4 2017 $25,353,000 31 Dec 2017 10-K 15 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.